Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.497
+0.127 (5.38%)
Sep 15, 2025, 11:04 AM EDT - Market open
Anebulo Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$8.00
Upside
+220.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 23, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $6 → $3 | Strong Buy | Maintains | $6 → $3 | +20.12% | May 15, 2025 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +220.33% | Nov 19, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +220.33% | Oct 1, 2024 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +220.33% | Oct 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.25% | Sep 25, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +140.25% | Sep 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +140.25% | Sep 18, 2023 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +220.33% | May 18, 2023 |
| Benchmark | Benchmark | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +220.33% | Feb 14, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +140.25% | Jul 27, 2022 |
| Benchmark | Benchmark | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +500.62% | May 25, 2021 |